A. O. Smith (AOS)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-10-29
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-10-29
Research Workspace
Put AOS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Building Products is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — EPS between $3.60 and $3.90 in FY26: Diluted EPS: $0.93 per share.
View ThesisRevenue is contracting — down about 1% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 13%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAOS’s North America growth and execution must offset flat revenue and challenging China conditions. Q3 revenue was flat year over year, while non-GAAP EPS beat by 3.3%. AOS trades at 17× P/E versus the 19× peer median. The price reflects less growth than our forecast, despite that peer discount. The FY26 EPS pillar remains under pressure against its $3.60 to $3.90 range. Our model puts the next-quarter miss probability near 24%. Peer multiples imply a price about 10% below where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-30. AOS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 15 analysts currently covering AOS (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare AOS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AOS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Building Products — fair value, gap to price, and forward P/E.
Compare the value case
Put AOS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete the strategic transaction for the China business
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Expected sales growth and a stated CPE closing timeline advance growth and China-transaction objectives.

Advances: Drive North America growth and operational execution
An official quarterly earnings call provides material updates on North America growth and operational execution.

Threatens: Manage challenging conditions in China market
Selling control of China operations materially changes the plan for managing a challenging market.

Threatens: Manage challenging conditions in China market
China market weakness impacts management's growth objectives.
Advances: Increase share repurchase target to $300 million in 2026
Higher buybacks support capital allocation objectives.
Advances: Lower full-year 2026 EPS outlook
Narrowing EPS outlook aligns with management's guidance objective.

Advances: Increase consolidated sales by 2% to 5%
Sales beat supports growth objective and overall thesis.
Threatens: Manage challenging conditions in China
Highlights ongoing challenges in China affecting performance.